Provider review
LillyDirect Foundayo review
Direct from the manufacturer, but requires a prescription written elsewhere first
LillyDirect Foundayo is Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss, launched as one of the cheapest legal paths to a brand-name GLP-1 in 2026: $25/month with the Lilly Savings Card for commercially insured patients, or $149-$299/month cash-pay depending on labeled dose. There's no compounding and no third-party reseller — direct from the manufacturer. But LillyDirect itself does not write the prescription; it requires a valid one from a separate licensed prescriber first, and the $25 savings card is restricted to commercial insurance — Medicare and Medicaid patients aren't eligible. Foundayo's own prescribing information shows lower mean weight loss at the labeled dose (11.1%) than Wegovy (14.9%) or Zepbound (20.9%), and it requires a strict empty-stomach 30-minute window before other food or drink.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
LillyDirect Foundayo is Eli Lilly's own direct-pay channel for Foundayo (orforglipron), a daily oral GLP-1 pill requiring no injections or refrigeration. With the Lilly Savings Card, commercially insured patients pay $25/month; cash-pay patients pay $149-$299/month depending on labeled dose — one of the cheapest legal paths to a brand-name GLP-1 available in 2026, sold direct from the manufacturer with no compounding and no reseller markup. It requires a valid prescription from a separate licensed prescriber — LillyDirect itself doesn't write one — and the $25 savings card excludes Medicare and Medicaid patients. Foundayo's own labeling shows lower mean weight loss at the labeled dose (11.1%) than Wegovy (14.9%) or Zepbound (20.9%), and dosing requires a strict 30-minute empty-stomach window.
LillyDirect Foundayo is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You already have a prescription and want to buy Foundayo direct from the manufacturer, no reseller markup
- You have commercial insurance and can access the $25/month savings-card rate
- You want an oral pill with no injections or refrigeration required
Look elsewhere if
- You're on Medicare or Medicaid — the $25/month savings card isn't available to you
- You don't yet have a prescription — LillyDirect doesn't write one
- You're comparing efficacy directly against Wegovy or Zepbound — Foundayo's labeled-dose weight loss is lower than both
What it actually costs
What they advertise
"$25/month" with the Lilly Savings Card (commercial insurance only); "$149-$299/month" cash-pay depending on labeled dose, per lillydirect.lilly.com.
What you actually pay, month to month
The $25/mo figure requires commercial insurance and the savings card; Medicare and Medicaid patients pay the $149-$299/mo cash-pay range instead.
The commitment trap
The $25/mo figure is restricted to commercially insured patients with the savings card; Medicare and Medicaid patients — ineligible for the card — pay $149-$299/mo instead.
Checked live on LillyDirect Foundayo's own site at https://lillydirect.lilly.com/pharmacy-solutions/foundayo in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what LillyDirect Foundayo bundles in, and what it does not.
Clinician consult
Not included
— requires a valid prescription from a separate licensed prescriber; LillyDirect does not prescribe.
Bloodwork / labs
Not addressed in the sources read.
Follow-ups and dose changes
Not addressed with a specific cadence in the sources read.
Human support
Not itemized in the sources read.
Injection supplies
Not itemized in the sources read.
Shipping
Not addressed with specific terms in the sources read.
Pharmacy, labs and oversight
The pharmacy
Direct from the manufacturer, Eli Lilly — no compounding, no third-party reseller.
Oversight
Not included — requires a valid prescription from a separate licensed prescriber; LillyDirect does not prescribe. Not addressed with a specific cadence in the sources read.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
All 50 states, per the homepage.
The honest cons
The part they would rather you skipped
The cheapest advertised path ($25/month) is closed to Medicare and Medicaid patients entirely, and the drug itself, per its own prescribing information, delivers less weight loss at the labeled dose than either Wegovy or Zepbound — worth knowing before choosing it purely on price.
- $25/month savings card requires commercial insurance — Medicare and Medicaid not eligible
- Requires an existing prescription from a separate prescriber — LillyDirect does not write one
- Lower labeled-dose weight loss (11.1%) than Wegovy (14.9%) or Zepbound (20.9%), per Foundayo's own prescribing information
- Strict empty-stomach 30-minute dosing window may be hard for some patients to follow
None of this is unique to LillyDirect Foundayo — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that board ranks them. LillyDirect Foundayo is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- BHBodybuilding Health+One of the deepest peptide catalogues here, and the loosest one
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Direct MedsThe plainest price mechanics on either board, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
- Sprout HealthA $150 markdown the site never explains, and a semaglutide price quoted by the quarter
- Strut HealthInjection or troche, but $119 is the auto-refill price only
- MadeMedPrices are published — but there is no monthly option at all
7 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect LillyDirect Foundayo's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on LillyDirect Foundayo's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.